GB1372541A - Cyclopentane derivatives - Google Patents

Cyclopentane derivatives

Info

Publication number
GB1372541A
GB1372541A GB3304971A GB5839971A GB1372541A GB 1372541 A GB1372541 A GB 1372541A GB 3304971 A GB3304971 A GB 3304971A GB 5839971 A GB5839971 A GB 5839971A GB 1372541 A GB1372541 A GB 1372541A
Authority
GB
United Kingdom
Prior art keywords
formula
cyclopenta
prepared
yloxy
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3304971A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE786251D priority Critical patent/BE786251A/xx
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB3304971A priority patent/GB1372541A/en
Priority to IE876/72A priority patent/IE36914B1/xx
Priority to CA145,746A priority patent/CA986926A/en
Priority to AU43940/72A priority patent/AU470384B2/en
Priority to JP6895172A priority patent/JPS5629665B1/ja
Priority to DD164374A priority patent/DD102141A5/xx
Priority to HUIE518A priority patent/HU166719B/hu
Priority to CH1046572A priority patent/CH575902A5/xx
Priority to FR7225520A priority patent/FR2145697B1/fr
Priority to SE7209266A priority patent/SE399706B/xx
Priority to NL7209817A priority patent/NL7209817A/xx
Priority to DE2234709A priority patent/DE2234709C2/de
Publication of GB1372541A publication Critical patent/GB1372541A/en
Priority to SE7504707A priority patent/SE7504707L/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
GB3304971A 1971-07-14 1971-12-16 Cyclopentane derivatives Expired GB1372541A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
BE786251D BE786251A (fr) 1971-07-14 Nouveaux derives du cyclopentane
GB3304971A GB1372541A (en) 1971-07-14 1971-12-16 Cyclopentane derivatives
IE876/72A IE36914B1 (en) 1971-07-14 1972-06-22 Cyclopentane derivatives
CA145,746A CA986926A (en) 1971-07-14 1972-06-26 Cyclopentane derivatives
AU43940/72A AU470384B2 (en) 1972-06-27 Cyclopentane derivatives
JP6895172A JPS5629665B1 (enExample) 1971-07-14 1972-07-10
HUIE518A HU166719B (enExample) 1971-07-14 1972-07-12
DD164374A DD102141A5 (enExample) 1971-07-14 1972-07-12
CH1046572A CH575902A5 (enExample) 1971-07-14 1972-07-12
FR7225520A FR2145697B1 (enExample) 1971-07-14 1972-07-13
SE7209266A SE399706B (sv) 1971-07-14 1972-07-13 Prostansyraderivat till anvendning som kontraceptiva medel, for avbrytande av havandeskap och for reglering av ostruscykeln
NL7209817A NL7209817A (enExample) 1971-07-14 1972-07-14
DE2234709A DE2234709C2 (de) 1971-07-14 1972-07-14 Prostanoesäurederivate und Verfahren zu deren Herstellung
SE7504707A SE7504707L (enExample) 1971-07-14 1975-04-23

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3304971 1971-07-14
GB3304971A GB1372541A (en) 1971-07-14 1971-12-16 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
GB1372541A true GB1372541A (en) 1974-10-30

Family

ID=26261688

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3304971A Expired GB1372541A (en) 1971-07-14 1971-12-16 Cyclopentane derivatives

Country Status (12)

Country Link
JP (1) JPS5629665B1 (enExample)
BE (1) BE786251A (enExample)
CA (1) CA986926A (enExample)
CH (1) CH575902A5 (enExample)
DD (1) DD102141A5 (enExample)
DE (1) DE2234709C2 (enExample)
FR (1) FR2145697B1 (enExample)
GB (1) GB1372541A (enExample)
HU (1) HU166719B (enExample)
IE (1) IE36914B1 (enExample)
NL (1) NL7209817A (enExample)
SE (2) SE399706B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096902A (en) * 1996-02-29 2000-08-01 Allergan Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
EP1551418A4 (en) * 2002-09-19 2006-05-03 Ilex Oncology Res Sarl SUBSTITUTED KETOPHOSPHONATE COMPOUNDS WITH BONE ANABOLIC EFFECT
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361410A1 (fr) * 1972-07-13 1978-03-10 Pfizer Alkylphosphonates de dialkyle, utiles comme intermediaires de synthese de prostaglandines
US4113723A (en) 1972-07-13 1978-09-12 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE420857T1 (de) 1988-09-06 2009-01-15 Pfizer Health Ab Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
HU212570B (en) * 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096902A (en) * 1996-02-29 2000-08-01 Allergan Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6573390B2 (en) 1996-02-29 2003-06-03 Allergan, Inc. Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6680337B2 (en) 1996-02-29 2004-01-20 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
EP1551418A4 (en) * 2002-09-19 2006-05-03 Ilex Oncology Res Sarl SUBSTITUTED KETOPHOSPHONATE COMPOUNDS WITH BONE ANABOLIC EFFECT
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative

Also Published As

Publication number Publication date
DD102141A5 (enExample) 1973-12-05
SE7504707L (enExample) 1975-04-23
IE36914B1 (en) 1977-03-30
BE786251A (fr) 1973-01-15
AU4394072A (en) 1974-01-03
FR2145697B1 (enExample) 1976-04-16
CA986926A (en) 1976-04-06
FR2145697A1 (enExample) 1973-02-23
CH575902A5 (enExample) 1976-05-31
NL7209817A (enExample) 1973-01-16
DE2234709A1 (de) 1973-02-01
IE36914L (en) 1973-01-14
JPS5629665B1 (enExample) 1981-07-09
HU166719B (enExample) 1975-05-28
SE399706B (sv) 1978-02-27
DE2234709C2 (de) 1982-06-03

Similar Documents

Publication Publication Date Title
US4147877A (en) ω-aryl-6-hydroxy-PGE1 compounds
US4096179A (en) 13,14-Dihydro-16-phenoxy prostaglandin F1α analogs
EP0087237B1 (en) Carbacyclin analogues
GB1372541A (en) Cyclopentane derivatives
US4112224A (en) Biheterocyclic-9,11-trideoxy-PGF compounds
IE38241L (en) Prostanoic acid derivatives
GB1386146A (en) Cyclopentane derivatives
EP0086611B1 (en) 9-substituted carbacyclin analogues
GB1398340A (en) Prostaglandins
GB1396206A (en) Prostaglandins and the preparation thereof
IE36421B1 (en) Cyclopentane derivatives
GB1472131A (en) Alkyl derivatives of prostanoic acids and preparation thereof
GB1502409A (en) Prostaglandin intermediates
US4223157A (en) 6-Keto-ωaryl-PGE1 compounds
US4533749A (en) 9-Substituted carbacyclin analogs
GB1497011A (en) 2-(omega-haloalkenyl-cyclopentane-1-heptanoic acids methods for preparation thereof and their use
GB1494588A (en) Prostaglandins
IE39569B1 (en) Cyclopentane derivatives
IE40571B1 (en) Cyclopentane derivatives
US4628110A (en) Novel 9-substituted carbacyclin analogs
GB1449147A (en) Prostaglandin intermediates method for electro coating metal surfaces with carbon
US4235997A (en) 6-Alkoxy-ω-aryl-PGI1 compounds
US4251466A (en) 2-Decarboxy-2-hydroxymethyl-6-keto-PGE1 compounds
US4590297A (en) Novel 9-substituted carbacyclin analogs
US4410695A (en) 2-Decarboxy-2-tetrazolyl-6-keto-PG compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee